Autoimmunity in Alzheimer's disease: Increased levels of circulating IgGs binding Aβ and RAGE peptides

Shyamala Mruthinti, Jerry J. Buccafusco, William D Hill, Jennifer L Waller, Thomas W. Jackson, Edward Y. Zamrini, Rosann F. Schade

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Plasma samples derived from 33 Alzheimer's disease (AD) and 42 control participants were subjected to several steps to purify specific anti-(amyloid)Aβ IgGs. Affinity-purified IgGs binding the peptide Aβ1-42, a neurotoxic sequence derived from the trans-membrane amyloid precursor protein, exhibited nearly four-fold higher titers in AD patients compared with their control non-AD cohort. Affinity-purified IgGs binding a fragment of the receptor for advanced glycation end products (RAGE) likewise were increased nearly three-fold in AD individuals. Aβ and RAGE IgG titers were negatively correlated with cognitive status, i.e. the more cognitively impaired individuals tended to exhibit higher IgG titers. Aβ IgG titers were negatively correlated with age in the control group, but not with the AD group. Levels of circulating Aβ̃- and RAGE-like proteins were not different between AD and control participants, nor was there a relationship between individual IgG titers and the respective Aβ- and RAGE-like proteins. Freshly prepared leukocyte preparations were subjected to flow cytometric analysis. AD individuals exhibited significantly increased populations of cells expressing binding sites for monoclonal antibodies directed against Aβ (5.5-fold), βAPP (3.5-fold), and RAGE (2.6-fold) relative to the control group. These findings confirm the presence of circulating IgGs specifically directed at proteins implicated in immunological processes linked to AD. The close relationship between titers for Aβ and RAGE IgGs suggests the possibility that the antibodies are being produced in response to a common mechanism or protein complex (with the respective epitopes) linked to the disease.

Original languageEnglish (US)
Pages (from-to)1023-1032
Number of pages10
JournalNeurobiology of Aging
Volume25
Issue number8
DOIs
StatePublished - Sep 1 2004

Fingerprint

Autoimmunity
Alzheimer Disease
Peptides
Immunoglobulin G
Amyloid
Proteins
Control Groups
Advanced Glycosylation End Product-Specific Receptor
Epitopes
Membrane Proteins
Leukocytes
Binding Sites
Monoclonal Antibodies
Antibodies
Population

Keywords

  • Advanced glycation end products
  • Affinity purification
  • Amyloid β protein
  • Anti-amyloid IgG
  • Auto-immunity

ASJC Scopus subject areas

  • Neuroscience(all)
  • Aging
  • Clinical Neurology
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Autoimmunity in Alzheimer's disease : Increased levels of circulating IgGs binding Aβ and RAGE peptides. / Mruthinti, Shyamala; Buccafusco, Jerry J.; Hill, William D; Waller, Jennifer L; Jackson, Thomas W.; Zamrini, Edward Y.; Schade, Rosann F.

In: Neurobiology of Aging, Vol. 25, No. 8, 01.09.2004, p. 1023-1032.

Research output: Contribution to journalArticle

Mruthinti, Shyamala ; Buccafusco, Jerry J. ; Hill, William D ; Waller, Jennifer L ; Jackson, Thomas W. ; Zamrini, Edward Y. ; Schade, Rosann F. / Autoimmunity in Alzheimer's disease : Increased levels of circulating IgGs binding Aβ and RAGE peptides. In: Neurobiology of Aging. 2004 ; Vol. 25, No. 8. pp. 1023-1032.
@article{5f3a590a78d44c848e6378018204dc35,
title = "Autoimmunity in Alzheimer's disease: Increased levels of circulating IgGs binding Aβ and RAGE peptides",
abstract = "Plasma samples derived from 33 Alzheimer's disease (AD) and 42 control participants were subjected to several steps to purify specific anti-(amyloid)Aβ IgGs. Affinity-purified IgGs binding the peptide Aβ1-42, a neurotoxic sequence derived from the trans-membrane amyloid precursor protein, exhibited nearly four-fold higher titers in AD patients compared with their control non-AD cohort. Affinity-purified IgGs binding a fragment of the receptor for advanced glycation end products (RAGE) likewise were increased nearly three-fold in AD individuals. Aβ and RAGE IgG titers were negatively correlated with cognitive status, i.e. the more cognitively impaired individuals tended to exhibit higher IgG titers. Aβ IgG titers were negatively correlated with age in the control group, but not with the AD group. Levels of circulating Aβ̃- and RAGE-like proteins were not different between AD and control participants, nor was there a relationship between individual IgG titers and the respective Aβ- and RAGE-like proteins. Freshly prepared leukocyte preparations were subjected to flow cytometric analysis. AD individuals exhibited significantly increased populations of cells expressing binding sites for monoclonal antibodies directed against Aβ (5.5-fold), βAPP (3.5-fold), and RAGE (2.6-fold) relative to the control group. These findings confirm the presence of circulating IgGs specifically directed at proteins implicated in immunological processes linked to AD. The close relationship between titers for Aβ and RAGE IgGs suggests the possibility that the antibodies are being produced in response to a common mechanism or protein complex (with the respective epitopes) linked to the disease.",
keywords = "Advanced glycation end products, Affinity purification, Amyloid β protein, Anti-amyloid IgG, Auto-immunity",
author = "Shyamala Mruthinti and Buccafusco, {Jerry J.} and Hill, {William D} and Waller, {Jennifer L} and Jackson, {Thomas W.} and Zamrini, {Edward Y.} and Schade, {Rosann F.}",
year = "2004",
month = "9",
day = "1",
doi = "10.1016/j.neurobiolaging.2003.11.001",
language = "English (US)",
volume = "25",
pages = "1023--1032",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Autoimmunity in Alzheimer's disease

T2 - Increased levels of circulating IgGs binding Aβ and RAGE peptides

AU - Mruthinti, Shyamala

AU - Buccafusco, Jerry J.

AU - Hill, William D

AU - Waller, Jennifer L

AU - Jackson, Thomas W.

AU - Zamrini, Edward Y.

AU - Schade, Rosann F.

PY - 2004/9/1

Y1 - 2004/9/1

N2 - Plasma samples derived from 33 Alzheimer's disease (AD) and 42 control participants were subjected to several steps to purify specific anti-(amyloid)Aβ IgGs. Affinity-purified IgGs binding the peptide Aβ1-42, a neurotoxic sequence derived from the trans-membrane amyloid precursor protein, exhibited nearly four-fold higher titers in AD patients compared with their control non-AD cohort. Affinity-purified IgGs binding a fragment of the receptor for advanced glycation end products (RAGE) likewise were increased nearly three-fold in AD individuals. Aβ and RAGE IgG titers were negatively correlated with cognitive status, i.e. the more cognitively impaired individuals tended to exhibit higher IgG titers. Aβ IgG titers were negatively correlated with age in the control group, but not with the AD group. Levels of circulating Aβ̃- and RAGE-like proteins were not different between AD and control participants, nor was there a relationship between individual IgG titers and the respective Aβ- and RAGE-like proteins. Freshly prepared leukocyte preparations were subjected to flow cytometric analysis. AD individuals exhibited significantly increased populations of cells expressing binding sites for monoclonal antibodies directed against Aβ (5.5-fold), βAPP (3.5-fold), and RAGE (2.6-fold) relative to the control group. These findings confirm the presence of circulating IgGs specifically directed at proteins implicated in immunological processes linked to AD. The close relationship between titers for Aβ and RAGE IgGs suggests the possibility that the antibodies are being produced in response to a common mechanism or protein complex (with the respective epitopes) linked to the disease.

AB - Plasma samples derived from 33 Alzheimer's disease (AD) and 42 control participants were subjected to several steps to purify specific anti-(amyloid)Aβ IgGs. Affinity-purified IgGs binding the peptide Aβ1-42, a neurotoxic sequence derived from the trans-membrane amyloid precursor protein, exhibited nearly four-fold higher titers in AD patients compared with their control non-AD cohort. Affinity-purified IgGs binding a fragment of the receptor for advanced glycation end products (RAGE) likewise were increased nearly three-fold in AD individuals. Aβ and RAGE IgG titers were negatively correlated with cognitive status, i.e. the more cognitively impaired individuals tended to exhibit higher IgG titers. Aβ IgG titers were negatively correlated with age in the control group, but not with the AD group. Levels of circulating Aβ̃- and RAGE-like proteins were not different between AD and control participants, nor was there a relationship between individual IgG titers and the respective Aβ- and RAGE-like proteins. Freshly prepared leukocyte preparations were subjected to flow cytometric analysis. AD individuals exhibited significantly increased populations of cells expressing binding sites for monoclonal antibodies directed against Aβ (5.5-fold), βAPP (3.5-fold), and RAGE (2.6-fold) relative to the control group. These findings confirm the presence of circulating IgGs specifically directed at proteins implicated in immunological processes linked to AD. The close relationship between titers for Aβ and RAGE IgGs suggests the possibility that the antibodies are being produced in response to a common mechanism or protein complex (with the respective epitopes) linked to the disease.

KW - Advanced glycation end products

KW - Affinity purification

KW - Amyloid β protein

KW - Anti-amyloid IgG

KW - Auto-immunity

UR - http://www.scopus.com/inward/record.url?scp=2942739009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942739009&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2003.11.001

DO - 10.1016/j.neurobiolaging.2003.11.001

M3 - Article

C2 - 15212827

AN - SCOPUS:2942739009

VL - 25

SP - 1023

EP - 1032

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 8

ER -